Diquafosol
|
- ₹0
- Product name: Diquafosol
- CAS: 59985-21-6
- MF: C18H26N4O23P4
- MW: 790.31
- EINECS:
- MDL Number:MFCD09837994
- Synonyms:[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-phosphinic acid;Diquafosol;Diquafosol [inn:ban];Diquafosol [inn];Kpy 998;p1,p4-Bis(5'-uridyl) tetrahydrogen tetraphosphate;Unii-7828vc80fj;P1,P4-Diuridine 5'-Tetraphosphate
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|
Properties
Density :2.044±0.06 g/cm3(Predicted)
solubility :Water (Slightly)
pka :0.40±0.50(Predicted)
form :Solid
color :White to Pale Beige
Stability :Hygroscopic
solubility :Water (Slightly)
pka :0.40±0.50(Predicted)
form :Solid
color :White to Pale Beige
Stability :Hygroscopic
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Diquafosol is a dinucleoside derivative of uridine that acts as a selective P2Y2 receptor agonist. Diquafosol is used as a therapeutic agent in the treatment of dry eye syndrome.More related product prices
Pranoprofen Tafluprost DUTP, 100MM SOLUTION 116295-90-0 UMP 27821-45-0 3387-36-8 28053-08-9 19817-92-6Related product price
- Pranoprofen
₹3669.68-14299.83 - DUTP, 100MM SOLUTION
₹20112.85 - 116295-90-0
₹8887.33-27571.28
Suppliers and manufacturers
SynZeal Research Pvt Ltd
Pharmaffiliates Analytics and Synthetics P. Ltd
Pharma Affiliates
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Hefei TNJ Chemical Industry Co.,Ltd.
AFINE CHEMICALS LIMITED
Finetech Industry Limited
